BUZZ-BioCardia drops as co raises equity after Thursday's surge

Reuters08-30

** BioCardia Inc's shares down 11.7% at $3.55 on Fri after co capitalizes on big pop in its stock to raise equity

** Cell therapy provider's shares on Thurs closed up ~83% at $4.02, a day after US FDA cleared its heart device, called Morph DNA Steerable Introducer

** Co early Fri announced pricing public offering of 2.4 mln shares and warrants to buy up to 2.4 mln shares at $3 for $7.2 mln gross proceeds

** Management and directors, institutional investors, certain existing investors participated in offering, co said

** 5-yr warrants have exercise price of $3, and exercisable immediately

** Co, which has ~2.1 mln shares outstanding, plans to use net proceeds for working capital, general purposes

** With move on the session, stock down 64% in 2024 and well off 1-yr closing high of $16.05 hit in Nov

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@thomsonreuters.com lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment